CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
Advances CytoSorb as a Potentially Revolutionary Therapeutic Advance to Reverse Deadly Shock in Critically Ill and Cardiac Surgery PatientsPRINCETON, N.J., Aug. 31, 2023 -- CytoSorbents Corporation...
United States Phillip Chan Mateus Biazus Alexandre Franco Kathleen Bloch Brazilian Health Regulatory Agency
Source: marketscreener.com